Detalles de la búsqueda
1.
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Int J Clin Oncol
; 29(3): 258-265, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310597
2.
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
Acta Oncol
; 62(4): 381-390, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37083566
3.
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study.
Anticancer Drugs
; 33(7): 663-670, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35703239
4.
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
Cancer Invest
; 39(6-7): 473-481, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014777
5.
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.
Int J Clin Oncol
; 26(8): 1506-1513, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023933
6.
Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer.
J Oncol Pharm Pract
; 22(1): 46-53, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25233884
7.
Targeted therapy for breast cancer.
Am J Pathol
; 183(4): 1096-1112, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23988612
8.
Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG).
Clin Genitourin Cancer
; 22(3): 102077, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626660
9.
A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
Medicine (Baltimore)
; 103(21): e37972, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38787994
10.
Demographic and Clinical Features of Patients with Metastatic Breast Cancer: A Retrospective Multicenter Registry Study of the Turkish Oncology Group.
Cancers (Basel)
; 15(6)2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980554
11.
Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
J Cancer Res Clin Oncol
; 149(14): 13271-13277, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480524
12.
Predictive role of neutropenia under crizotinib treatment in ALK-rearranged nonsmall cell lung cancer patients: A single-institution retrospective analysis.
Indian J Cancer
; 59(2): 251-256, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35017371
13.
Evaluation of Treatment Efficacy of Tyrosine Kinase Inhibitors in Rare Single EGFR Exon 21 L861Q Mutation: Single Center Experience.
Turk Thorac J
; 23(4): 290-295, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35848437
14.
PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment.
Turk Thorac J
; 23(1): 45-51, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110200
15.
The effectiveness of cetuximab and panitumumab when combined with FOLFIRI in second-line treatment of KRAS wild type metastatic colorectal cancers. Single centre experience.
J Chemother
; 33(3): 180-186, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33349195
16.
Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle for Bimodal Imaging and Treatment of Cancer as a Novel Theranostic Platform.
Curr Radiopharm
; 14(1): 23-36, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32282311
17.
Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences.
Eur Urol Focus
; 7(5): 1061-1066, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33008789
18.
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report.
Ann Clin Microbiol Antimicrob
; 9: 27, 2010 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20849666
19.
Reply To the Editor, Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315.
J Oncol Pharm Pract
; 21(4): 318-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25979298
20.
Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer.
Cancer Cell
; 37(3): 387-402.e7, 2020 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32142667